1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal MetastasesPMMR/Ras/BRAF Wild-type; Unresectable Colon Cancer Peritoneal MetastasesRecruitingPhase 22023-02-24NCT05742425